AIM: To gain new insights into tumor metabolism and to identify possible biomarkers with potential diagnostic values to predict tumor metastasis. METHODS: Human gastric cancer SGC-7901 cells were implanted into 24 severe combined immune deficiency (SCID) mice, which were randomly divided into metastasis group (n = 8), non-metastasis group (n = 8), and normal group (n = 8). Urinary metabolomic information was obtained by gas chromatography/mass spectrometry (GC/MS). RESULTS: There were significant metabolic differences among the three groups (t test, P < 0.05). Ten selected metabolites were different between normal and cancer groups (non-metastasis and metastasis groups), and seven metabolites were also different between non-metastasis and metastasis groups. Two diagnostic models for gastric cancer and metastasis were constructed respectively by the principal component analysis (PCA). These PCA models were confirmed by corresponding receiver operating characteristic analysis (area under the curve = 1.00). CONCLUSION: The urinary metabolomic profile is different, and the selected metabolites might be instructive to clinical diagnosis or screening metastasis for gastric cancer.
AIM: To gain new insights into tumor metabolism and to identify possible biomarkers with potential diagnostic values to predict tumor metastasis. METHODS:Humangastric cancer SGC-7901 cells were implanted into 24 severe combined immune deficiency (SCID) mice, which were randomly divided into metastasis group (n = 8), non-metastasis group (n = 8), and normal group (n = 8). Urinary metabolomic information was obtained by gas chromatography/mass spectrometry (GC/MS). RESULTS: There were significant metabolic differences among the three groups (t test, P < 0.05). Ten selected metabolites were different between normal and cancer groups (non-metastasis and metastasis groups), and seven metabolites were also different between non-metastasis and metastasis groups. Two diagnostic models for gastric cancer and metastasis were constructed respectively by the principal component analysis (PCA). These PCA models were confirmed by corresponding receiver operating characteristic analysis (area under the curve = 1.00). CONCLUSION: The urinary metabolomic profile is different, and the selected metabolites might be instructive to clinical diagnosis or screening metastasis for gastric cancer.
Entities:
Keywords:
Biomarker; Gas chromatography/mass spectrometry; Gastric cancer; Metabolomic profile; Metastasis
Authors: Pär Jonsson; Jonas Gullberg; Anders Nordström; Miyako Kusano; Mariusz Kowalczyk; Michael Sjöström; Thomas Moritz Journal: Anal Chem Date: 2004-03-15 Impact factor: 6.986
Authors: Pär Jonsson; Annika I Johansson; Jonas Gullberg; Johan Trygg; Jiye A; Bjørn Grung; Stefan Marklund; Michael Sjöström; Henrik Antti; Thomas Moritz Journal: Anal Chem Date: 2005-09-01 Impact factor: 6.986
Authors: Thorhallur Agustsson; Mikael Rydén; Johan Hoffstedt; Vanessa van Harmelen; Andrea Dicker; Jurga Laurencikiene; Bengt Isaksson; Johan Permert; Peter Arner Journal: Cancer Res Date: 2007-06-01 Impact factor: 12.701